Brief: Klaria Pharma Gets Notice Of Allowance From Patent Office In U.S.
Jan 21 (Reuters) - Klaria Pharma Holding AB (publ) KLAR.ST :
* GETS NOTICE OF ALLOWANCE FROM PATENT OFFICE IN U.S.
* PATENT-PROTECTED MARKET EXCLUSIVITY IN U.S. VALID UNTIL 2036
* PATENT MEANS EXTENSION OF MARKET EXCLUSIVITY IN U.S. BY 7 YEARS
* EXPECTS EXTENSION TO INCREASE ESTIMATED ACCUMULATED SALES OF THE PRODUCT bY MORE THAN $1
BLN
Source text for Eikon: ID:nWkr10kvKp
Further company coverage: KLAR.ST
(Gdansk Newsroom)
((gdansk.newsroom@thomsonreuters.com; +48 58 778 51 10;))
Recent news on Klaria Pharma Holding AB (publ)
See all newsBrief: Klaria Gets Additional Subscription Commitments, Extends Subscription Period
Brief: Klaria Pharma Publishes Summary Of External Valuation
Brief: Klaria Pharma To Decide On Rights Issue Of Up To SEK 147.6 Mln
Brief: Klaria Pharma To Carry Out Rights Offering
Brief: Klaria, RTHS Enter Collaboration Agreement